Corbus Pharmaceuticals Holdings Inc
Change company Symbol lookup
Select an option...
CRBP Corbus Pharmaceuticals Holdings Inc
PTI Proteostasis Therapeutics Inc
CALB California BanCorp
$NOPM2 Refinitiv Norway Metal & Mining Inde
EBAY eBay Inc
PTON Peloton Interactive Inc
GO Grocery Outlet Holding Corp
NUE Nucor Corp
SJM J M Smucker Co
KR Kroger Co
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Corbus Pharmaceuticals Holdings, Inc. is a Phase-III, clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company operates through developing and commercializing therapeutics to treat rare life-threatening inflammatory fibrotic diseases segment. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and halt fibrotic processes. Lenabasum stimulates the production of Specialized Pro-Resolving Lipid Mediators (SPMs) that act to resolve inflammation, and halt fibrosis by activating endogenous pathways. The Company is developing lenabasum to treat four diseases: systemic sclerosis, cystic fibrosis, diffuse cutaneous, skin-predominant dermatomyositis and systemic lupus erythematosus (SLE).

Postmarket

Last Trade
Delayed
$1.22
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$1.22
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
1.26
Day's Low
1.18
Volume
(Light)
Volume:
3,095,348

10-day average volume:
4,789,899
3,095,348

American Airlines Names Douglas M. Steenland to its Board of Directors

5:00 pm ET October 8, 2020 (Globe Newswire) Print

American Airlines Group Inc. (NASDAQ: AAL) today announced the election of Douglas M. Steenland, 69, to its board of directors. Steenland also will serve on the company's finance and compensation committees.

"We are delighted Doug has agreed to join our board and we welcome his extensive airline experience to our boardroom," said Chairman and CEO Doug Parker. "Importantly, Doug's expertise expands across the broader travel and hospitality sector, and our team and company will be well served by his experience and counsel."

Steenland currently is non-executive chairman of the board of directors of American International Group and serves as the lead independent director of Hilton Worldwide Holdings. Steenland held numerous senior roles over his 17-year career at Northwest Airlines Corporation, most notably as CEO from April 2004 to October 2008 and as president from 2001 to 2004. He retired from Northwest when it merged with Delta Air Lines in 2008.

Prior to Northwest, Steenland was a partner at Verner Liipfert, which is now part of DLA Piper, and he also worked in the Office of the General Counsel of the U.S. Department of Transportation. He holds a Bachelor of Arts from Calvin College and a J.D. from The George Washington University Law School.

About American Airlines Group

American's purpose is to care for people on life's journey. Shares of American Airlines Group Inc. trade on Nasdaq under the ticker symbol AAL and the company's stock is included in the S&P 500. Learn more about what's happening at American by visiting news.aa.com and connect with American on Twitter @AmericanAir and at Facebook.com/AmericanAirlines.

Corporate Communications

mediarelations@aa.com

https://ml.globenewswire.com/media/ee9646a2-bf4d-4673-95fd-9c41b00a70da/small/aagroup-logo-jpg.jpg

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.